Imexpharm Corp (IMP) — Financial Flexibility Index
Imexpharm Corp (IMP) has a Financial Flexibility Index of 0.25x as of March 2026. Free cash flow of ₫111.28 Billion (operating CF ₫103.49 Billion minus capex ₫7.79 Billion) represents 0% of total liabilities (₫442.31 Billion). Check Imexpharm Corp strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Imexpharm Corp Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Imexpharm Corp across 7 annual periods. See IMP net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Imexpharm Corp (2019–2025)
Year-by-year free cash flow to debt coverage for Imexpharm Corp. For the full company profile including market capitalisation, see Imexpharm Corp stock valuation.
| Year | Flexibility Index | Free Cash Flow (VND) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | ₫81.05 Billion | ₫54.17 Billion | ₫476.11 Billion | ▼ -82.5% |
| 2024 | 0.97x | ₫313.04 Billion | ₫216.27 Billion | ₫321.66 Billion | ▲ +1225.1% |
| 2023 | 0.07x | ₫22.62 Billion | ₫-40.47 Billion | ₫308.04 Billion | ▼ -94.1% |
| 2022 | 1.25x | ₫477.96 Billion | ₫378.60 Billion | ₫382.50 Billion | ▲ +117.3% |
| 2021 | 0.58x | ₫287.74 Billion | ₫234.88 Billion | ₫500.29 Billion | ▲ +29.3% |
| 2020 | 0.44x | ₫162.84 Billion | ₫73.15 Billion | ₫365.97 Billion | ▼ -35.1% |
| 2019 | 0.69x | ₫197.72 Billion | ₫66.59 Billion | ₫288.29 Billion | — |